• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ALT

ALT

Altimmune, Inc.

NASDAQHealthcareBiotechnologyUS

USD2.87

-0.03 (-1.03%)

Rating:C+

Company Profile

CEO

Jerome Benedict Durso

IPO Date

2017-05-26

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$2.93

Prev. Close

$2.90

Day Low

$2.84

Day High

$2.95

52W Low

$2.56

52W High

$7.73

Market Cap

$0.25B

Volume

3.02M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

39.2%

Avg Negative

47.3%

Avg Neutral

13.7%

News Feed

Why Altimmune Is Crashing Today

The Motley Fool·6/30/2021·↓ negative

ALT Stock Price Falls Over 35%: Why It Happened

Pulse2·6/30/2021·↓ negative

ALT in Freefall After Covid-19 Vaccine Trials Scrapped

Schaeffers Research·6/30/2021·↓ negative

Altimmune Stock Tanks On Double Bad News From COVID-19 Program

Benzinga·6/30/2021·↓ negative

Altimmune stock falls after it drops development of nasal COVID-19 vaccine

Market Watch·6/29/2021·↓ negative

Altimmune Announces Update on AdCOVID™ Phase 1 Clinical Trial

GlobeNewsWire·6/29/2021·↑ positive

ALT Stock Price Increased 16.49%: Why It Happened

Pulse2·6/17/2021·↑ positive

Altimmune, Inc. (ALT) Soars 16.5%: Is Further Upside Left in the Stock?

Zacks Investment Research·6/17/2021·↑ positive

Altimmune's Stock Trades In A Double Bottom Pattern: What's Next?

Benzinga·6/16/2021·↑ positive

Here's Why Altimmune Stock Is Surging Today

The Motley Fool·6/16/2021·↑ positive